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I feel very privileged to be invited
to be your Stoneburner Lecturer for
this year. When I came to consider
what I really wanted to say and what
might interest people in widely different areas of medicine, there really
was little choice. I perhaps can claim
to be able to talk about emphysema
from a rather broader standpoint than
some other physicians. Not because I
suffer from it, which is sometimes a
good reason for talking about a disease, but because I have been trained
both in England and in America, and
the outlook on this disease has differed
in Europe and in the States.
I started work on emphysema under
the guidance of Dr. Christie in 1948,
and in 1948 no one was much interested in the disease. I worked in Philadelphia in 1952, and there I gave a
lecture on emphysema which was so
controversial that it was disbelieved.
The climate is different now, and I
am talking about something of which
most of you already know a fair
amount. I have selected it as a topic
because, whether you are a public
health administrator, an internist, an
allergist, an anesthetist, a surgeon, or
even just a cigarette smoker, you
should be interested in this condition.
One reason for contemporary concern about this disease is the considerable increase in the standardized mortality in the United States since 1945,
for what physicians call on the death
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certificate "emphysema and fibrosis."
The rate of increase of lung cancer
has been similar, but since 1955 the
diseases categorized as "emphysema"
have been increasing more rapidly
than has lung cancer. Over the same
period, of course, mortality from tuberculosis has dipped. But the puzzle
of nomenclature can be seen from
the fact that bronchitis, as certified in
the United States, has apparently not
increased at all as a cause of mortality.
If I were to show you a comparable
graph from Europe, bronchitis would
appear to h ave been the main cause
of the increased mortality, and emphysema to a much smaller extent. I
think we now realize that this is purely
a semantic matter. Differences are
not great between different industrialized communities in any of these diseases. It has been largely a matter of
what the physician has called the
condition he has looked at.
Certified causes of death at best
are enigmatic and subject to shifting
classification. The autopsy incidence
of morphological emphysema as found
in 138 random autopsies of inflated
right lungs at the Massachusetts General Hospital in Boston has been reported by Dr. Thurlbeck. With reference to men only, and by dividing the
autopsy population into 12 decades
of age, the incidence of quite obvious
morphological emphysema, excluding
the little bits of emphysema at the
apices and other minor forms, is striking. Once men are in the fifth and
sixth decades, half of the random au-

11, 1964.

top•y populotion •how• oon•i\

34

ob1'

morphological emphysema. The same
data in identical form are found in my
own hospital in Montreal. So Montreal
and Boston have a virtually identical
autopsy incidence. Many pathologists
have emphasized that the true incidence of emphysema can only be evaluated if the lungs are inflated. If they
are fixed when collapsed, he will underestimate the incidence of this condition by at least half; and second, he
will not be in a position to see, as I
will show you in a few moments, its
most damaging form. When the Massachusetts General Hospital group is
broken down into categories, the malefem ale incidence is very different.
In 59 females, 45 had no detectable
morphological emphysema. In 79
males, only 25 had no emphysema.
This reflects the 4: 1 prevalence of
emphysema in men.
There is another reason why this
group of diseases has become very important. You will recall the major episode of smog in London in 1952, but
you may have forgotten that this episode killed 4,000 people in 6 days. The
smog lasted from December 2 until
14, approximately. London is so large
that it took the Registrar General's
figures 3 weeks to catch up on the
surplus mortality of 4,000 people. So
this is another reason why this disease
has become important.
The First Challenge

The first of emphysema's three challenges is to understand not what the
acute episode can do, which we know
very well in a population with some
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lung disease, but to understand what
lesser degrees of atmospheric pollution
do, not over 6 days but over 20 years.
I fancy it will be a long time before
we understand the interrelationship
between the acute sensational phenomenon and the chronic unsensational mortality.
I grew up in an era when chronic
bronchitis did not have a respectable
pathology. In Boyd's Pathology for
1947, chronic bronchitis was not a respectable disease. It was mainly an
important complication of tuberculosis, or it was sometimes a nuisance in
people with heart disease, but as a
primary pathological entity it was
little regarded. It is worth reminding
you that now it has a highly respectable and extremely carefully quantified pathological existence, depending
on hypertrophy of the bronchial mucous glands.
Now it is time we took up some
practical examples of the kind of patient you deal with, and we deal with.
I am not going out of my way to
speak of the only case I have seen in
5 years that represented so and such.
I am talking about things that I believe are extremely common. The first
patient was a 66-year-old man who
worked all his life with the Canadian
Pacific Railway, largely an office job,
and gave a rather clear history of
some breath shortness for 2 years,
some chronic cough for perhaps 15
years, not very much sputum, and an
occasional episode of respiratory infection. He had dyspnea for 1 year.
The function tests were done when he

had one such episode while in another
hospital. He had left that hospital diagnosed as having arteriosclerotic heart
disease. They found an abnormal EKG ,
swollen ankles, liver two fingersbreadth's enlarged, and a normal chest
film. When he was studied in the function lab in November, 1958, the findings were: a vital capacity about half of
what it should be, a lung volume much
bigger than it ought to be-gross overinflation, and markedly uneven gas distribution. The F.E.V. (forced expiratory volume) should have been 70 L per
minute, but was only 19 L per minute.
His airflow rate should have been 3 L
per second, but was only 0.2 L per
second; therefore, he had terrible ventilatory obstruction. The transport of
carbon monoxide, or the diffusing capacity, should have been about 14 and
was 7 ml per minute per mm of Hg.
This tells us either he had very uneven ventilation/ perfusion distribution
in the lung, which is commonly found ,
or he had a reduced surface area for
gas exchange, or a thickened alveolar
membrane. His arterial C02 tension
was 56 mm of Hg, and the pH 7.4. You
know, therefore, this was a chronic situation because he had brought his bicarbonate up to adjust the pH. The
oxygen saturation was a little down.
About 9 months after these tests were
done he came to the hospital with a
very severe pneumonia, and he died
as a tracheotomy was being done. The
whole lung section of this man show,ed
black areas which look at a distance
like currants. These are holes which
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go from the bottom to the top. They
can be better shown if you outline the
normal lung with barium (fig. 1). You
are now close to what killed him, an
example of severe widespread centrilobular emphysema. Each of these
holes is roughly in the center of the
lobule, and around it is an area of remaining normal alveoli. Virtually no
lobule anywhere in either lung is
spared. When this lung was allowed to
collapse and sectioned in the normal
way, it was reported as being normal.
This lesion is exceedingly hard to see if
you allow the lung to collapse. When
these holes collapse, they approximate;
the alveoli in between are normal, and
the pathologist, by allowing the lung
to collapse, has put himself in the
worst possible position to see the lesion responsible for the disease. It was
Gough in Cardiff who separated out
this form of emphysema from others.
He called it centrilobular emphysema.
It is a good name and it was the first
step forward in differentiating the pathology of this disease. One of the
mysteries of emphysema is why this
is such a lethal condition. The man I
showed you had normal coronary arteries. His right ventricle was hypertrophied and not his left. (He had no
arteriosclerotic heart disease although
this had been diagnosed.) The only
thing he died of was his severe CO,
retention, which came upon him when
he got pneumonia. However, he had
had hypercapnia chronically for several years. The mystery is why this lesion, which can be quite minimal and
unspectacular, so often gives rise to
such severe blood gas disturbance.
The Second Challenge

FIG. I-Whole lung section from patient
with centrilobular emphysema. Barium
added for clearer demarcation.
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This brings me to challenge number
two; that is, to understand much more
fully than we do at the moment the
interrelationship between the structural changes, which the pathologist
can picture, and the functional derangement responsible for the patient
getting to the pathologist at all. This
is something which many people are
working on, and I can only present
you with the problem and stimulate
you to this extent: that there probably
is no disease of an organ as big as the
lung in which 75 % of the alveoli can
be intact, and yet in which you die
from its consequences. There must be
something then about the situation of

this lesion in the middle of the lobule
at the end of the bronchiole which is
particularly harmful. It is remarkable
that you cannot get along with 25%
of your lung gone, if it happens that
this destruction has occurred at the
end of each terminal bronchiole.
There was a period in which people
used to chat about the tremendous reserve of the lung. They said you could
take one lung out of a man and he
could walk upstairs. That is fine . He
can, but you punch out the center of
each lobule and he has a very limited
prognosis.
My second example is of a man
about the same age as the previous
man, to illustrate the clues you can
get in life that the lesion is centrilobular emphysema. This man's pulmonary
function tests were similar to those of
the first patient, also showing severe
ventilatory defect and hypercapnia
(table 1). This man happens to still be
alive. But I wanted to mention him
because of his chest x-rays (fig. 2a) .
In the close-up of a carefully taken
bronchogram, where plenty of time
was allowed for the material to get
into the pools, the major bronchi are
fairly normal, but when it gets to the
periphery it fills the pools. Simon and
Reid have called these the "Lily of the
Valley" sign, as the total picture is
rather like a lily of the valley (fig. 2b ).
If you will take a lung with centrilobular emphysema and inject it in
the autopsy room, you get a very similar picture. There is a hole, and furthermore there is considerable distortion of bronchi. The pool is filled at
the end. So you can get a clue from
bronchography. As I will show you in
a moment, there is quite a different
sort of emphysema which clinically
may be almost indistinguishable from
this one.
I am not going to talk in this lecture about details of technique of
study, because these are of interest
only to people working in this field. I
am going to take a jump, however, to
describe briefly a technique, because I
want to show you what you may learn
with it. I am not going into great detail. The point I want you to get is
the result. The research group with
whom I work has been busy for 4
years working on what may be learned
by studying how the lung handles radioactive xenon. Xenon is a radioactive gas that you can breathe in very
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safely, and measure from outside the
chest what the lung is doing with it
(fig. 3). A subject having such a study
has behind him six scintillation counters, positioned in particular places in
relation to the chest x-ray, three on
one side and three on the other. With
this method, you can get an idea of
what each bit of the lung is doing;
sometimes, as I will show you, with
very surprising results. Then you can
use it another way. You can dissolve
xenon in saline and put it in the arm
vein, and watch its clearance into lung
alveoli. Of what gets to an alveolus,
95% will be cleared into the gas phase.
I think it is quite obvious, without a
lot of mathematics, that in this way
you can quantify the ventilation which
each lung zone is getting, and its
blood distribution, as shown by this
study. A complete examination of the
kind I have very briefly described
gives you rather less than one-half the
radiation of a single chest film, so
there is no serious radiation hazard in
the use of this particular isotope.
Now I am going to show you what
happens if you do this very simple experiment. It takes a few minutes of
the patient's time and a lot of instrumentation, but you can learn a lot
from it. Figure 4 shows the three
counter positions on each side-six
rings where the counters were positioned on this patient. The patient is a
46-year-old woman who had been com-

FIG. 4-Location of xenon counters in
relation to chest film.

TABLE 1

Pulmonary function report of Mr . A. H . M., age 61 , who had minimal sputum for
IO years (<IO cc per day) and dyspnea on exercise for 5 years.

Vital capacity . . . . .
. .. .. .. . . .
Functional residual capacity ... . .. . . . .. .
Mixing efficiency . .
. ... . .. . . .. . . .. ...... .
Forced expiratory volume... . ...... .. . . . . . .. . . .
Maximum midexpiratory flow rate ..
Arterial
pC0 2 ••••

• • • • •..

pH .
HCO'a.
Resting CO diffusion .

2 .1 L
5.4 L
37%
19 L/ min

0.24 L/ sec
58 mm Hg

7.4

34.5 mM/ L
5.3 ml CO/ min X mm Hg

Fm. 2-Chest x-ray (a) and bronchogram (b) of patient A. H. M.

Fm. 3-Xenon scintillation counters in position.
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plaining of breathlessness for 2 years.
She had never smoked more than two
cigarettes a day, and she never had any
sputum, not even enough for a specimen. When she became dyspneic, no
one really would believe her. The
chest film was thought to be normal;
physical examination of the heart was
normal; the electrocardiogram was
normal, and the blood pressure was
normal. The only thing was her repeated statement that she was short of
breath. The physical signs of the lungs
were minimal. I think the only thing
to make you suspicious was that the
breath sounds were a little hard to
hear in someone who was quite thin,
as she weighed only about 105 pounds ;
she had lost a bit of weight. She was
so incapacitated with dyspnea that she
could cook standing up at the stove
only with difficulty. Of course, the
consequence of the combination of
these findings is that you get referred
to psychiatry. This she had for 6
months without noticeable benefits,
except that her own views on psychiatrists became much better defined
than they had been in the past!
Comparing predicted values for a
woman of this size and age, as we have
in three series of studies (table 2), you
can see how consistent the pu!mcnary
function findings were. Her vital capacity final!y came down to 900 ml.
The lung volume initially was not big,
but became bigger. The total lung
capacity was about correct. The gas
distribution was very poor. Her venti1ation was appalling, maximum midexpiratory flow rate, unaffected by
bronchodilators, very bad indeed. The
resting diffusing capacity was onethird normal, and on hyperventilation
we managed to get a reading of 5.6.
This told us that something was very
badly wrong with distribution and gas
exchange. However, there was no C02
retention , and the oxygen saturation
was not strikingly abnormal. This is the
kind of case one should show all residents from the start, since the arterial blood can be a bad indicator of
pulmonary abnormality. You can be incapacitated for years and have normal
arterial blood. It is often misused in
practice by people who have not had
enough experience with these diseases
who place too much reliance on this
as a test of function. It is very important to know it, but it is very important not to place too much dependence
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FIG.

5- Section of right lower lobe from patient L. B., showing panlobular emphysema.

TABLE 2

Pulmonary function report of Mrs . L.B., age 46. See Fig. 4 for x-ray.
Pre- April ,
dieted 1958
--- -

Vital capacity (L) .
.. .
Functional residual capacity (L). .. .
Total lung capacity (L) .
Mixing efficiency (3) .
Forced expiratory volume 0 75 X 40 (indirect maximum breathing capacity) (L/ min).
Maximum midexpiratory flow rate (L/ sec) . .. . ..
Resting CO diffusion (ml/ mm Hg X min ) . . . . .
Arterial blood
pH
. . . . . . . . ' . . . . . . . . . . . . . . . . . . .. . . .
pCO, (mm Hg) . . . . . . . . . . . . . . . . . . . .. . . .. . .
0 2 Hb saturation (3).
. . . . . . . ... .. . .. .

May,
1960

April,
1961

-- --- ---

2.8
1. 3
2.6
2.6
4.2
3.4
: 22
60

1. I
3 .1
3.8
37

0 .9
3.5
4.1
17

76
3.7
14.0

13
0.17
4.6

15
0.20
4.3

11

7.4
40
94

7.42
40
90

7.41
43
95

7 .37
40
91

0. 15
4.4

TABLE 3

Xenon 133 distribution indices of Mrs. L. B.
Right

Left

Upper

Mid

Lower

Upper

Mid

Lower

Tidal breath . ... . . . .
Predicted. .. . . ... .

139
58

33*
70

12*
87

88*
57

29*
70

106*
91

Perfusion . .... . . ..
Predicted.

249
38

69
70

79
67

86
129

61
137

278
42

* Abnormally slow clearance observed from these sites.

on it. I will show you why this woman's arterial blood was normal, because it is quite clear when you see
where the ventilation and perfusion
were going, that they were fairly accurately matched. It is worth stressing
that you can be in a desperate situation
from a ventilation point of view for
years, without any change in the arterial blood. This is another part of the
challenge of relating structure to function.
(Table 3) Now, the xenon technique
I showed you ends up as a series of
numbers, and I am not going into the
derivation of these numbers; we call
them distribution indices. Their magnitude is not very important, but they
tell us the amount of ventilation going
into different portions of one lung and
the other. What I want you to notice is
that, on simple tidal breathing, instead
of there being slightly more ventilation
in the lower than the upper, on the
right side there is a 10-fold difference,
and perfusion distribution on the right
side is also reduced. Almost all the perfusion is going through the upper part
of the right lung, and much less in the
lower. As you sit there, upright, which
is the position she was studied in, you
have about four times as much perfusion through the lower as the upper, so
that in normal subjects the upper zone
counter is about 60, and in her it was
about 150. There is much better ventilation in the left lower zone. It is
much better, in fact, than the left
upper. However, we have the same
imbalance of blood distribution, so
that we now know what we never
would have guessed from the chest
film, let alone from the stethoscope,
that the right lower zone has grossly
impaired ventilation and perfusion.
Presumably this is one of the main
areas that has been destroyed. With
these people who have been almost
entirely incapacitated for years who
are below the age of 50, we have on
occasion taken out lobes that are doing nothing. Figure 5 shows what her
right lower lobe looked like. This was
a completely destroyed lobe. It was
destroyed this time not in the centrilobular fashion showed in the first
patient, but generally destroyed. This
often is referred to as panacinar or
pan lobular
emphysema.
Already,
therefore, we have made a differentiation. This is a youngish woman with
very little smoking history, virtually

no bronchitis, and at least one lobe of
her lung, and probably the left lower
as well, has been destroyed. At operation, the right upper looked normal,
but I do not believe it was completely
normal. We got m arginal improvement in function by taking out the
lower lobe. She was just able to go
out and walk around the block. She
is still alive. The blood gases are exactly as they always were. To return
to that point about the blood gases,
when one lobe, in her case the right
upper, is getting most of the ventilation and most of the perfusion, there
is no imbalance. The lung manages to
keep the arterial blood normal, but
half the right thorax is occupied by a
lobe which is idle in terms of ventilation and perfusion. It was because we
believed then, as we do now, that this
destroyed lobe in some circumstances
can interfere with the ventilation of
the more normal lobe on the same
side that the lobectomy was performed.
I wanted to show you a similar
situation in a man of about the same
age. If you study chest x-rays and
tomograms carefully, by looking very
carefully at the vasculature, you can
get some idea where the blood is going. Figure 6 shows the angiogram of
a patient in whom radioactive xenon
studies were performed. These showed
that the left upper zone was getting
about five-sixths of both ventilation and
perfusion. It was all he had to live on.
He had been incapacitated for 4 years.
The angiogram shows clearly the predominant perfusion of the left upper
zone. If the pathological differentiation
were as clear-cut as I h ave just made
it, we would be on very good ground.
But that isn't so. Often these two lesions occur together in the same lung.
This is a commonplace finding when
you look at autopsy m aterial. Before
one gets fancy about differential etiology, it is important to remember
that whatever theory you construct
may have to explain the simultaneous
incidence of the two lesions in the
same lung.
One of the points of the radioactive
xenon technique is to see whether it
can tell us not only what one lobe, or
zone, is doing in relation to others,
which is an interesting thing to know,
but also whether, by some refinement
or trick, it can tell us anything about
the distribution of blood and gas oc39

FIG. 6-Angiogram of patient with pan-

lobular emphysema. The upper lobes are
relatively spared.

curring within a specific zone. Although we have gone only a little way
with this kind of differentiation, it is
worth mentioning. We are trying to
develop means of measuring effective
ventilation within zones or counter
fields, in the hope that differences may
reflect varying pathological types of
emphysema. We think this may become very important because it seems
to us that the pattern of centrilobular
emphysema usually has this kind of
imbalance. This is the first clue we
have had in 10 years of work that
might get us closer to the differential
function of these different types of
emphysema.
The Third Challenge

FIG. 7-Chest film of a young asthmatic.
X-ray alone could lead to a mistaken diagnosis of emphysema.

Now, my third challenge in emphysema is, of course, to the clinician.
It is to challenge him to be able to
differentiate in life between bronchitis, asthma, and emphysema. It is
really a challenge to get close to the
morphology of the lung of the patient
he is treating. In other words, how
can he find out what the morphology
was like, not merely afterward when
we have the lung to look at, but during
life? Most physicians would agree that
this is very difficult. It is very difficult
in the Jung because the x-rays are,
with some exceptions, of rather little
value. The physical examination is almost worthless and is as often misleading in terms of differentiation as
it is helpful. By that I mean, that if
the chest is barrel-shaped, I still don't
know what's happening to the Jung
underneath. Not only do I not know,
but I know that y ou don't know, and
no amount of talking on the chest

contour in relation to lung morphology will convince me that you can do
very well with a tape measure, or
standing and looking at the plain x-ray
film. The better pathologists you have,
the worse you will find you are doing.
One kind of x-ray is often diagnosed
in x-ray departments as indicating
emphysema. The one in figure 7 belongs to a radio weather forecaster,
so that if I listen to the weather forecast in the morning at half-past seven,
I can hear whether he's wheezing.
He's a young man of 28. He has a
clear history of allergy in the family,
suffers from hay fever, and is an asthmatic; never very severe but never
completely free of bronchospasm. The
plain film could easily deceive a radiologist into thinking this might be
destroyed lung. On examination in the
pulmonary laboratory (table 4), he
had an impaired vital capacity. His
lung was somewhat over inflated, as
the residual volume is a 1,300 ml too
big. The ratio of residual volume to
total lung volume, which some people
like to think of as a measure of emphysema, was elevated. The gas distribution was poor, the ventilation was
diminished, and the maximum midexpiratory flow rate was quite considerably down. The resting diffusing
capacity, however, was above normal.
When you see this phenomenon of a
normal diffusing capacity by a steadystate method, you can go out on a
limb and say you never have that kind
of diffusing capacity when your lung
parenchyma is destroyed. That is the
only way you can really use it. When
it's like this, regardless of how bad
the ventilation is, regardless of how

TABLE 4

Pulmonary function report of Mr. F. E., age 28, who had spasmodic asthma.
Blood gas tensions were normal. Xenon studies: slight prolongation of wash in
and washout in all zones; normal indices of perfusion and ventilation distribution;
no disparity between clearance of " ventilated" and " perfused" lung.

Vital capacity (L) ...
Functional residual capacity (L) . . .. .. . . . . .
Residual volume ... . .... .
Residual volume/ total lung capacity (% ) . . ... . . . .. .
Mixing efficiency (%) .. . .. .. . . . ........... .
Forced expiratory volumeo.75 X 40, (indirect maximum
breathing capacity) (L/ min) . . .
Maximum rnidex piratory flow rate (L/ sec) .... . . . . . . . . .
Resting CO diffusion (ml/ min X mm Hg) .. .

40

Predicted

Observed

5.6
4.2
2.0
26
65

3.4
3.8
3.3
49.5
34

140
4 .50
23. 5

83
1.30
33 .0

bad the gas distribution is, you'll never
lose your money if you bet on a normal parenchyma. Of course such patients rarely get to pathology, so you
don't win much because these asthmatics do not tend to die. But this
tells you his lung parenchyma must be
intact, regardless of what the x-ray
department thinks. When you study
such a man with a single breath of inspired xenon, you find that his regional gas distribution is normal. He
has no gross change in perfusion distribution either. But when you study
him on a steady state experiment, you
find in this particular man that the
right upper and lower zones have a
very considerably impaired ventilation. I show him because I don't know
why his asthma is not a uniform phenomenon. I don't know why it has
singled out two zones, but this appears
to be a common feature in asthmatics.
It is important to stress that spasmodic
asthma does not of itself give rise to
emphysema. They are utterly and
completely distinct phenomena. In
terms of xenon distribution, asthma
does not appear to cause the kind of
gross upset of perfusion distribution
you commonly see with a destroyed
lobe, nor does it cause the imbalance
between ventilation and perfusion
clearance you may see in centrilobular emphysema. What it does cause is
regional ventilation impairment without much change of perfusion. There
is an upset of ventilation-perfusion
distribution, but it is a consequence
of the ventilation change, the perfusion being very much as normal.
In this differentiation between emphysema and asthma, there is one important bit of evidence I have not
dwelt on or shown you anything
about. That is, in emphysema, at a
certain lung volume, which we'll say
is 4.5 L, the transpulmonary pressure, or the pressure between the
esophagus and the mouth, is much less
negative than in normal people. Asthmatics, however, whether over or under 20, follow more or less the normal
curve for lung recoil. If you destroy
alveoli, you cut down the normal recoil of the lung, which is quite a useful way of knowing whether you are
looking at an asthmatic lung with a
normal recoil, or whether you're looking at one which has destroyed alveoli. This simple test is not used
anything like enough, and we have

evidence that it very rarely lets you
down.
There must be 15 theories of the etiology in emphysema and you are quite
entitled to take your pick among
these. It is probably as good as anyone else's pick. But that is not really
the question we can yet ask. We have
to be sure we are looking at one condition. We have to be sure that we
have refined our understanding of the
relationship between the structural
change, which the pathologists can
show us, and the function defect, as
far as we can. Only then can we talk
meaningfully about differentiations in
this disease in life. And when the
practicing physician is faced with a
man of 45 with a chronic cough and
a good deal of dyspnea, he is challenged to predict what the lung is like.
Until he seriously tries to do this, it's
extraordinarily hard to realize how
bad the methods are at his disposal
to make any differentiation between
bronchitis with airway obstruction,
asthma with spasmodic airway obstruction, often chronic (both of those
having an intact lung parenchyma),
and the differing kinds of emphysema.
Only if he is worrying about the vascular pattern of the lung, only if, with
the support of the function Jab, he is
moving a little closer to excluding
people from one or another category,
can he really get a perception in his
own mind of how good or bad he is
at making this kind of clinical differentiation. This distinction is not
merely of academic interest. It is absolutely cardinal in understanding the
interrelationships of these diseases and
guessing intelligently at their etiology.
There is never any excuse for sloppy
clinical thinking; there is surely every
reason to encourage people to sharpen
it to the maximum. The first thing you
learn when you try to predict accurately the morphology of the lung in
people, and follow them over a long
period of time, is that in this main endeavor, we have hardly yet begun.

"It is surprising, perhaps, to realize how many people at one time
or another exert some sort of medical function. The old-world grandmother who nursed a dozen cases
of measles in her own children does
not hesitate to make a diagnosis
on her young grandchild, nor to
tell her daughter precisely what to
do. The arthritic may sing the
praises of flannel cloths and goosefat; the newspaper editor may
freely recommend a "reducing
diet," and the pharmacist a sleeping-pill or headache remedy. Laymen who give such advice are
relying on experience. Often the
advice seems to work, perhaps not
perfectly, but at least to a gratifying degree.
"Many laymen have been extremely skilled in diagnosis and
have achieved considerable therapeutic success. However, giving
appropriate advice is only part of
medical skill-an important practical part, to be sure, but still only
a part. The layman can learn from
experience what to do, but the physician must also know why he does
what be does. He must know it in a
manner quite detailed, clear and rational, organized and logical. It
is this knowledge which sets off
the physician from the layman ...
Aristotle made the distinction quite
explicit, that almost anyone can
learn
procedure
empirically,
through rule of thumb, but whoever lays claim to scientific knowledge must know the reasons and
the general principles."
Lester S. King, The Growth
of M edical Thought. Chicago: The University of
Chicago Press, 1963, pp.
1-2.

41

